Moberg Pharma AB announced that the company's Nomination Committee has decided to present the following proposal to the Annual General Meeting 2019. The Nomination Committee proposes that Thomas Eklund is elected as Chairman of the Annual General Meeting of shareholders 2019. Thomas Eklund has, after three years as Chairman of the Board and four years as Board member, chosen to resign.

Geert Cauwenbergh, Sara Brandt and Anna Malm Bernsten have chosen not to be available for re-election in order to enable a composition of the Board of Directors that is better adapted to the company's new situation and focus. The Nomination Committee proposes the appointment of Peter Wolpert as new Board member and executive Chairman of the Board of Directors, and Fredrik Granström as new Board member. Peter has offered to resign as CEO of the company and, to be available for election as Board member and Chairman of the Board of Directors of the company.